Recro Pharma, Inc. Gains 36.81%
Fri, Dec 11, 2020 at 05:33 PM
Recro Pharma, Inc. (REPH:NASDAQ) soared at $2.96, a gain of 36.8%. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 08:00 PM in the 'EARNINGS' category. From Fri 27 Nov 20, the stock recorded 22.22% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Recro Pharma, Inc. (REPH:NASDAQ)
Recro Pharma Inc is a specialty pharmaceutical company. It develops non-opioid products for treatment of serious acute pain. The Company operates through two business divisions: Acute Care division and contract development and manufacturing division.
Top 10 Gainers:
- TPGY (TPGY:NYSE), 116.22%
- MACU (MACU:NASDAQ), 100%
- Solid Biosciences Inc. (SLDB:NASDAQ), 51.62%
- Equus Total Return, Inc. (EQS:NYSE), 46.9%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 42.65%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 41.55%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 41.29%
- NextDecade Corporation (NEXT:NASDAQ), 38%
- Recro Pharma, Inc. (REPH:NASDAQ), 36.81%
- FAT Brands Inc. (FAT:NASDAQ), 28.08%